Charles Greg Guyer - 12 Nov 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
12 Nov 2024
Net transactions value
-$347,243
Form type
4
Filing time
14 Nov 2024, 14:44:40 UTC
Previous filing
07 May 2024
Next filing
27 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $3,080 +55 +0.07% $56.01 74,187 31 Oct 2024 Direct F1
transaction BMRN Common Stock Sale $350,324 -5,278 -7.1% $66.37 68,909 12 Nov 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
F2 The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.37 to $66.395. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.